2022-12-21 2023-12-31 false No description of principal activity Capium Accounts Production 1.1 14553431 bus:AbridgedAccounts 2022-12-21 2023-12-31 14553431 bus:Micro-entities 2022-12-21 2023-12-31 14553431 bus:AuditExempt-NoAccountantsReport 2022-12-21 2023-12-31 14553431 bus:SmallCompaniesRegimeForAccounts 2022-12-21 2023-12-31 14553431 bus:PrivateLimitedCompanyLtd 2022-12-21 2023-12-31 14553431 2022-12-21 2023-12-31 14553431 2023-12-31 14553431 bus:RegisteredOffice 2022-12-21 2023-12-31 14553431 core:WithinOneYear 2023-12-31 14553431 core:AfterOneYear 2023-12-31 14553431 bus:Director1 2022-12-21 2023-12-31 14553431 bus:Director1 2023-12-31 14553431 2021-12-21 14553431 bus:LeadAgentIfApplicable 2022-12-21 2023-12-31 14553431 2022-12-20 14553431 bus:OrdinaryShareClass1 2022-12-21 2023-12-31 14553431 bus:OrdinaryShareClass1 2023-12-31 14553431 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 14553431 core:CostValuation core:Non-currentFinancialInstruments 2022-12-20 14553431 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-12-31 14553431 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-12-31 14553431 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-12-31 14553431 core:Non-currentFinancialInstruments 2023-12-31 14553431 core:Non-currentFinancialInstruments 2022-12-20 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14553431
England and Wales

 

 

 

V DRUG LIMITED


Abridged Accounts
 


Period of accounts

Start date: 21 December 2022

End date: 31 December 2023
  2023
    £ £
Called up share capital not paid   1 
Current assets 11,422   
Creditors: amount falling due within one year (1,376)  
Net current assets   10,046 
Total assets less current liabilities   10,047 
Net assets   10,047 
 

     
Capital and reserves   10,047 
 
NOTES TO THE ACCOUNTS

General Information
V DRUG LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14553431, registration address 8 BAZLEY CLOSE, SWANSCOMBE UNITED KINGDOM, DA10 0FF.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the period was 2.


For the period ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 17 August 2024 and were signed by:


--------------------------------
Viorel DRUG
Director
1